Kaynes Technology Q1 Performance Review & Strategic Outlook

Financial Highlights Revenue: Surged 40% YoY to ₹946 crore, beating estimates of ₹866 crore. Core segments grew >30%, while niche verticals like Aerospace and Medical registered exceptional growth of 181% YoY. Profitability: EBITDA stood at ₹147.5 crore, outpacing estimates. However, EBITDA margins contracted to 15.6% (vs. 16.7% YoY). Gross margins narrowed to 34.4% (vs. 41.1%) due to supply-chain, energy, and commodity cost escalations. Operational Metrics & Outlook Order Book: Expanded to ₹8,900 crore (+20% YoY), maintaining a healthy 2.3x trailing 12-month sales ratio. Working Capital: The cash conversion cycle stretched to 163 days from 122 days YoY, driven by elevated inventory and receivables. Strategic Pipeline: Management anticipates profitability normalization in upcoming quarters. Key catalysts include the smart metering segment turning cash-positive by year-end, advanced talks with a leading global EV manufacturer, and a targeted prototype satellite launch by mid-next year. Analyst Perspectives While operational execution remains strong, brokerages flagged balance sheet deterioration and trimmed EPS estimates by 5%–11% due to higher depreciation and tax rates. Motilal Oswal (Buy | TP: ₹5,000): Projects a 41% revenue CAGR and 52% Adjusted PAT CAGR through FY26–FY28, driven by core EMS scaling and upcoming OSAT/PCB commercialization. JPMorgan & Nomura (Neutral): Acknowledged the revenue beat but remain cautious on elevated net working capital (NWC) and inventory days. CLSA (Hold) & Kotak (Reduce): Highlighted negative operating cash flow and declining Return on Capital Employed (RoCE) resulting from the stretched working capital cycle.